Search for: "Eli, Inc."
Results 481 - 500
of 1,001
Sorted by Relevance
|
Sort by Date
17 Jun 2008, 11:34 pm
Inc. a/a/o Jose Fernandez v. [read post]
15 Apr 2021, 1:42 pm
In August, the FDA declined to approve Gilead Inc’s experimental rheumatoid arthritis treatment filgotinib, which also belongs to the same class of oral drugs. [read post]
1 Apr 2011, 5:17 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
31 Jan 2018, 10:05 pm
Article 3(a): a spectrum of specificity The Court of Appeal reviewed the case law of the CJEU and pending references, focussing on Case C-322/10 Medeva BV v Comptroller-General of Patents, Designs and Trade Marks and Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc. [read post]
15 Jan 2015, 12:17 pm
See Speedplay, Inc. v. [read post]
17 May 2024, 9:37 pm
Eli Lilly & Co., 598 F.3d 1336 (Fed. [read post]
20 Mar 2014, 7:48 am
Eli Lilly & Co., 598 F.3d 1336, 1344 (Fed. [read post]
1 Mar 2013, 11:56 am
Management Solutions, Inc., a Texas Corporation; Wendell A. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
17 Oct 2008, 1:32 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation… [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of five patents owned by… [read post]
14 Jan 2010, 11:09 am
” Glaxo, Inc. v. [read post]
5 Jan 2022, 3:40 am
Corp., Home Equity Loan Trust, Series 2006-SL2 v DB Structured Prods., Inc., 25 NY3d 581, 593-594 [2015]; Ely-Cruikshank Co., 81 NY2d at 404). [read post]
7 Aug 2012, 11:45 pm
In Eli Lilly & Co. v. [read post]
21 May 2009, 2:00 am
Eli Lilly & Co.) [read post]
24 Oct 2011, 2:52 am
Human Genome Sciences Inc v Eli Lilly and Company, heard 18 July 2011. [read post]
2 May 2014, 10:23 am
Despite Auxilium Pharmaceuticals’ opposition, a joint response filed on behalf of other testosterone drug manufactures such as Abb Vie, Inc., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
7 Sep 2010, 12:25 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
30 Jul 2015, 11:50 am
” Announcement of the proposed legislation was joined by a letter of support on behalf of the Association of Global Automakers, Inc., Biotechnology Industry Organization (BIO), The Boeing Company, Boston Scientific, BSA | The Software Alliance (BSA), Caterpillar Inc., Corning Incorporated, Eli Lilly and Company, General Electric, Honda, IBM, Illinois Tool Works Inc., Intel, International Fragrance Association, North America, Johnson & Johnson, Medtronic,… [read post]
